This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Stowers Institute for Medical Research, The Childrens' Mercy Hospital, University of Kansas. Active years: 2025.
Company Filing History:
1 out of 33 
1 out of 25 
1 out of 571 
Years Active: 2025
Title: Fang Tao - Innovator in Cancer Treatment
Introduction
Fang Tao is a notable inventor based in Overland Park, KS (US). She has made significant contributions to the field of cancer research, particularly in developing methods to combat leukemia. Her innovative approach focuses on overcoming resistance to anti-cancer treatments.
Latest Patents
Fang Tao holds a patent titled "Methods for overcoming WNT/beta-catenin anti-cancer resistance in leukemia stem cells." This patent outlines methods for treating cancers, including leukemia, using low doses of an anthracycline such as doxorubicin. This groundbreaking work has the potential to improve treatment outcomes for patients suffering from leukemia.
Career Highlights
Throughout her career, Fang Tao has worked with esteemed institutions such as the Stowers Institute for Medical Research and Children's Mercy Hospital. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer treatment.
Collaborations
Fang Tao has collaborated with notable colleagues, including Linheng Li and John M. Perry. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in cancer research.
Conclusion
Fang Tao's work in developing methods to treat leukemia showcases her dedication to advancing cancer research. Her innovative approaches and collaborations with esteemed institutions highlight her impact on the field.